#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	19320	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2031	945.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	1109	C	992	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	0	.	n	.	0	A20C	SNP	20	20	A	320	320	C	602	C,A	565,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	0	.	n	.	0	T695C	SNP	695	695	T	995	995	C	1115	C,T	1005,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1938	1938	G	1187	G,A	1070,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2271	2271	C	1140	C,T	1016,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2345	2345	A	1138	A,C	1048,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34502	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3526	976.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2897	2897	C	1063	C,T	952,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2570	folP	855	855	100.0	folP.l6.c30.ctg.1	1533	167.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1033	1035	AGC	246;245;247	A;G;C	220;223;224	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7190	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3507	204.4	1	SNP	p	S91F	1	.	.	271	273	TTC	681	683	TTC	258;257;256	T;T;C	227;226;223	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7190	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3507	204.4	1	SNP	p	D95G	1	.	.	283	285	GGC	693	695	GGC	257;258;257	G;G;C	226;223;224	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7190	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3507	204.4	1	SNP	p	G95N	0	.	.	283	285	GGC	693	695	GGC	257;258;257	G;G;C	226;223;224	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2054	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1363	150.1	0	.	p	.	0	F184L	NONSYN	550	552	TTC	892	894	TTG	234;230;232	T;T;G	205;207;205	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2054	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1363	150.1	1	SNP	p	G45D	0	.	.	133	135	GGC	475	477	GGC	257;257;256	G;G;C	234;230;230	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	990	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1045	94.1	0	.	n	.	0	A197.	DEL	197	197	A	609	609	A	244	A	225	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7200	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2907	247.1	1	SNP	p	D86N	0	.	.	256	258	GAC	527	529	GAC	282;280;279	G;A;C	256;251;254	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7200	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2907	247.1	1	SNP	p	R87W	0	.	.	259	261	CGT	530	532	CGT	282;281;281	C,A;G;T	259,2;257;255	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7200	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2907	247.1	1	SNP	p	S87R	1	.	.	259	261	CGT	530	532	CGT	282;281;281	C,A;G;T	259,2;257;255	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7200	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2907	247.1	1	SNP	p	R87I	0	.	.	259	261	CGT	530	532	CGT	282;281;281	C,A;G;T	259,2;257;255	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	7200	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2907	247.1	1	SNP	p	S88P	0	.	.	262	264	TCC	533	535	TCC	277;279;278	T;C;C	250;257;256	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5770	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2684	214.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	264;260;260	G;G;C	237;231;230	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1200	1202	GCA	312;310;309	G;C;A	276;273;275	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1203	1205	ATC	303;306;303	A;T;C,A	271;274;269,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1215	1217	GTG	297;295;297	G;T;G	263;262;265	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1215	1217	GTG	297;295;297	G;T;G	263;262;265	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1719	1721	ACC	256;252;255	A;C;C	226;225;224	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1773	1775	GCG	268;267;263	G;C,G;G	224;210,1;215	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1773	1775	GCG	268;267;263	G;C,G;G	224;210,1;215	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1896	1898	AGC	231;230;231	A;G,A;C	213;209,1;210	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1905	1907	GGC	221;220;216	G;G;C,T	203;202;198,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5222	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2303	225.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1923	1925	CCG	188;191;188	C,G;C,G;G,C	124,10;134,3;132,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7496	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3055	244.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1606	1608	CCG	289;285;282	C;C;G	253;256;249	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2968	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1699	173.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	205	C	185	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	398	400	GAA	301;302;303	G;A;A,G	270;271;268,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	686	688	GAT	277;278;277	G;A;T,G	248;247;245,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	809	811	TCA	277;279;280	T;C;A	257;262;263	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	938	940	GTC	320;324;327	G;T;C	284;291;295	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	950	952	TCT	340;343;346	T;C;T	310;310;313	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	A296V	NONSYN	886	888	GCA	1172	1174	GTA	256;260;261	G;T,C;A	230;231,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1268	1270	GCA	294;298;298	G;C;A	263;265;266	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	1	SNP	p	G120K	1	.	.	358	360	AAG	644	646	AAG	295;296;298	A,G;A,G;G,T	267,1;269,1;266,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	1	SNP	p	A121D	1	.	.	361	363	GAC	647	649	GAC	295;296;293	G;A,C;C	266;265,1;266	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3532	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1469	239.2	1	SNP	p	D121N	0	.	.	361	363	GAC	647	649	GAC	295;296;293	G;A,C;C	266;265,1;266	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13384	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4776	279.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1378	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1108	124.1	1	SNP	p	V57M	1	.	.	169	171	ATG	557	559	ATG	310;310;310	A;T;G	280;278;280	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
